Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies

NCT05784415 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT05784415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05784415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Cohort Study of People Living With HIV Treated With CD19-directed CAR T Cell Therapy for B-cell Lymphoid Malignancies
Lead sponsor
AIDS Malignancy Consortium
Phase
Observational
Overall status
Completed
Start date
May 22, 2021
Completion date
November 14, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, hiv associated lymphoma, hiv disease; lymphoma, hiv infections, leukemia, leukemia, lymphoblastic, lymphoma, b-cell, lymphoma, follicular, lymphoma, large b-cell, diffuse, lymphoma, non-hodgkin